Publications

1. Scott HM, Mehta R, Branda ME, Hughes J, Kane SV, Girard S, Norgan AP, Theiler RN, Enninga EAL. Effect of Anti-TNF Biologic Exposure During Pregnancy on Villitis of Unknown Etiology Diagnoses in Patients with Autoimmune Disease. Reprod Sci. 2024 Apr; 31 (4):997-1005 Epub 2023 Nov 16
   View PubMed
2. Malter L, Hong SJ, Lopatin S, Murphy M, Hudesman D, Kane S, Rubin DT. Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience. Inflamm Bowel Dis. 2024 Jan 13 [Epub ahead of print]
   View PubMed
3. Gawey BJ, Guerrero Vinsard D, Own M, Kane SV. Saddle Nose Deformity in a Patient With Crohn's Disease. ACG Case Rep J. 2023 Dec; 10 (12):e01237 Epub 2023 Dec 15
   View PubMed
4. Ramkissoon R, Codipilly DC, Kane SV. Gastric Outlet Obstruction From a Massive Liver Abscess. Am J Gastroenterol. 2023 Sep 1; 118 (9):1539 Epub 2023 May 30
   View PubMed
5. Patel NB, Vinsard DG, Kattah AG, Kane SV. Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy. Dig Dis Sci. 2023 Sep; 68 (9):3557-3561 Epub 2023 July 05
   View PubMed
6. Ebner DW, Burger KN, Mahoney DW, Broderick BT, Eckmann JD, Devens ME, Lowrie KL, League JB, Bering J, Kahn A, Rodriguez EA, Prichard DO, Wallace MB, Kane SV, Leighton JA, Buttar NS, Rutten LJF, Gurudu SR, Kisiel JB. Neoplasia Diagnosis After Multi-target Stool DNA Is Enhanced Among Lowest Baseline Detectors. Dig Dis Sci. 2023 Sep; 68 (9):3721-3731 Epub 2023 July 24
   View PubMed
7. Ghusn W, Acosta A, Kane S. An Unusual Etiology of Bleeding in an Inflammatory Bowel Disease Surveillance Colonoscopy. Gastroenterology. 2023 Jul; 165 (1):40-43 Epub 2022 Dec 31
   View PubMed
8. Kane SV, Reau N. Clinical advances: pregnancy in gastroenterologic and hepatic conditions. Gut. 2023 May; 72 (5):1007-1015 Epub 2023 Feb 09
   View PubMed
9. Chugh R, Braga-Neto MB, Fredrick TW, Ramos GP, Terdiman J, El-Nachef N, Loftus EV, Mahadevan U, Kane SV. Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease. J Crohns Colitis. 2023 Apr 19; 17 (4):504-512
   View PubMed
10. Guerrero Vinsard D, Bruining DH, East JE, Ebner D, Kane SV, Kisiel JB, Leighton JA, Lennon RJ, Loftus EV Jr, Malik T, Picco M, Raffals L, Ramos GP, Santiago P, Coelho-Prabhu N. Interobserver agreement of the modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease. Gastrointest Endosc. 2023 Apr; 97 (4):790-798.e2 Epub 2022 Nov 17
    View PubMed
11. Rolak S, Kane SV. Rescue Therapy for Acute Severe Ulcerative Colitis: A Case Report. Gastroenterol Hepatol (N Y). 2023 Mar; 19 (3):176-179
    View PubMed
12. Johnson AM, Barsky M, Ahmed W, Zullow S, Galati J, Jairath V, Narula N, Peerani F, Click BH, Coburn ES, Dang TT, Gold S, Agrawal M, Garg R, Aggarwal M, Mohammad D, Halloran B, Kochhar GS, Todorowski H, Ud Din NM, Izanec J, Teeple A, Gasink C, Muser E, Ding Z, Swaminath A, Lakhani K, Hogan D, Datta S, Ungaro RC, Boland BS, Bohm M, Fischer M, Sagi S, Afzali A, Ullman T, Lawlor G, Baumgart DC, Chang S, Hudesman D, Lukin D, Scherl EJ, Colombel JF, Sands BE, Siegel CA, Regueiro M, Sandborn WJ, Bruining D, Kane S, Loftus EV Jr, Dulai PS. The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium. Am J Gastroenterol. 2023 Feb 1; 118 (2):317-328 Epub 2022 Sept 30
    View PubMed
13. Chen B, Collen LV, Mowat C, Isaacs KL, Singh S, Kane SV, Farraye FA, Snapper S, Jneid H, Lavie CJ, Krittanawong C. Inflammatory Bowel Disease and Cardiovascular Diseases. Am J Med. 2022 Dec; 135 (12):1453-1460 Epub 2022 Sept 02
    View PubMed
14. Kiran RP, Kochhar GS, Kariv R, Rex DK, Sugita A, Rubin DT, Navaneethan U, Hull TL, Ko HM, Liu X, Kachnic LA, Strong S, Iacucci M, Bemelman W, Fleshner P, Safyan RA, Kotze PG, D'Hoore A, Faiz O, Lo S, Ashburn JH, Spinelli A, Bernstein CN, Kane SV, Cross RK, Schairer J, McCormick JT, Farraye FA, Chang S, Scherl EJ, Schwartz DA, Bruining DH, Philpott J, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sandborn WJ, Silverberg MS, Pardi DS, Church JM, Shen B. Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 Sep; 7(9):871-893. Epub 2022 Jul 05.
    View PubMed
15. Guerrero Vinsard D, Karagozian R, Wakefield DB, Kane SV. Maternal Outcomes and Pregnancy-Related Complications Among Hospitalized Women with Inflammatory Bowel Disease: Report from the National Inpatient Sample. Dig Dis Sci. 2022 Sep; 67 (9):4295-4302 Epub 2021 Aug 18
    View PubMed
16. Isaacs K, Kane S. Doctor, What Is the Best Crohn's Therapy? Am J Gastroenterol 2022 Jul 1; 117 (7):1041-1043 Epub 2022 May 12
    View PubMed
17. Cohen BL, Fleshner P, Kane SV, Herfarth HH, Palekar N, Farraye FA, Leighton JA, Katz JA, Cohen RD, Gerich ME, Cross RK, Higgins PDR, Tinsley A, Glover S, Siegel CA, Bohl JL, Iskandar H, Ji J, Hu L, Sands BE. Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery. Gastroenterology. 2022 Jul; 163 (1):204-221 Epub 2022 Apr 10
    View PubMed
18. Moktan VP, Daoud ND, Tremaine WJ, Loftus EV Jr, Kane SV, Hochwald AP, Hodge DO, Hashash JG, Faubion SS, Farraye FA. A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease. Crohns Colitis 360. 2022 Jul; 4 (3):otac027 Epub 2022 Aug 04
    View PubMed
19. Rolak S, Kane SV. Conventional Therapies for Crohn's Disease. Gastroenterol Clin North Am. 2022 Jun; 51 (2):271-282 Epub 2022 Apr 22
    View PubMed
20. Fredrick TW, Ramos GP, Braga Neto MB, Kane S, Faubion WA, Loftus EV Jr, Pardi DS, Pasha SF, Farraye FA, Zhang L, Raffals LE. Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis. Crohns Colitis 360. 2022 Apr; 4 (2):otac008 Epub 2022 Mar 15
    View PubMed
21. White BA, Ramos GP, Kane S. The Impact of Alcohol in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2022 Mar 2; 28 (3):466-473
    View PubMed
22. Tirath A, Kane SV. Disease Flares in the Postpartum Period: Vigilance Is Key. Inflamm Bowel Dis 2022 Mar 2; 28 (3):484-485
    View PubMed
23. Kamboj AK, Kane SV, Leggett CL. Crohn's Disease of the Esophagus. Clin Gastroenterol Hepatol. 2022 Feb; 20 (2):A15-A16 Epub 2020 Oct 17
    View PubMed
24. Havlichek D 3rd, Guerrero Vinsard D, Pignolo RJ, Kane S. Crohn's Disease in a Patient With Fibrodysplasia Ossificans Progressiva. ACG Case Rep J. 2022 Jan; 9 (1):e00737 Epub 2022 Jan 25
    View PubMed
25. Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP, Fleshner P, McCormick JT, D'Hoore A, Shah SA, Farraye FA, Kariv R, Liu X, Rosh J, Chang S, Scherl E, Schwartz DA, Kotze PG, Bruining DH, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, Picoraro JA, Vermeire S, Sandborn WJ, Silverberg MS, Pardi DS. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 Jan; 7 (1):69-95 Epub 2021 Nov 10
    View PubMed
26. Lukin D, Faleck D, Xu R, Zhang Y, Weiss A, Aniwan S, Kadire S, Tran G, Rahal M, Winters A, Chablaney S, Koliani-Pace JL, Meserve J, Campbell JP, Kochhar G, Bohm M, Varma S, Fischer M, Boland B, Singh S, Hirten R, Ungaro R, Lasch K, Shmidt E, Jairath V, Hudesman D, Chang S, Swaminath A, Shen B, Kane S, Loftus EV Jr, Sands BE, Colombel JF, Siegel CA, Sandborn WJ, Dulai PS. Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis. Clin Gastroenterol Hepatol. 2022 Jan; 20 (1):126-135 Epub 2020 Oct 08
    View PubMed
27. Lakshmanan S, Kane S, Dibble C, Roland B. Need for Awareness and Training in Women's Gastrointestinal Health: A Call to Action. J Womens Health (Larchmt). 2022 Jan; 31 (1):125-129 Epub 2021 Apr 21
    View PubMed
28. Chowdhury R, Kane SV. Pregnancy and Crohn's disease: concerns and assurance of medical therapy. Gastroenterol Rep (Oxf). 2022; 10:goac055 Epub 2022 Oct 10
    View PubMed
29. Daoud ND, Ghoz H, Cannon R, Farraye JA, Picco MF, Kane SV, Kochhar GS, Woodhams EJ, Farraye FA. Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn's Disease. Crohns Colitis 360. 2022 Jan; 4 (1):otab078 Epub 2021 Nov 13
    View PubMed
30. Cho JM, Loftus EV Jr, Bruining DH, Chedid VG, Farraye FA, Faubion WA Jr, Johnson AM, Kane SV, Kisiel JB, Malik TA, Papadakis KA, Pardi DS, Picco MF, Raffals LE, Schroeder KW, Tremaine WJ, Coelho-Prabhu N. Vulvar Crohn's Disease: Clinical Features and Outcomes. Am J Gastroenterol. 2021 Nov 1; 116 (11):2296-2299
    View PubMed
31. Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, D'Hoore A, Schairer J, Farraye FA, Kiran RP, Fleshner P, Rosh J, Shah SA, Chang S, Scherl E, Pardi DS, Schwartz DA, Kotze PG, Bruining DH, Kane SV, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, McCormick JT, Picoraro JA, Silverberg MS, Bernstein CN, Sandborn WJ, Vermeire S. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2021 Oct; 6 (10):826-849 Epub 2021 Aug 18
    View PubMed
32. De Felice KM, Kane S. Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol. 2021 Sep; 148 (3):661-667
    View PubMed
33. Katz S, Kane SV. Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2021 Sep; 17 (9):415-419
    View PubMed
34. Atieh J, Chedid V, Khoshbin K, Kane S, Camilleri M. Development of a Score to Predict Positive Colonic Histology in Chronic Diarrhea Assessed in Open-access Colonoscopy. J Clin Gastroenterol. 2021 Sep 1; 55 (8):694-701
    View PubMed
35. Ramos GP, Dimopoulos C, McDonald NM, Janssens LP, Hung KW, Proctor D, Ruggiero E, Kane S, Bruining DH, Faubion WA, Raffals LE, Loftus EV, Al-Bawardy B. The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study. Inflamm Bowel Dis. 2021 Jul 27; 27 (8):1270-1276
    View PubMed
36. Holubar SD, Lightner AL, Poylin V, Vogel JD, Gaertner W, Davis B, Davis KG, Mahadevan U, Shah SA, Kane SV, Steele SR, Paquette IM, Feingold DL, Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative Colitis. Dis Colon Rectum. 2021 Jul 1; 64 (7):783-804
    View PubMed
37. Ramos GP, Al-Bawardy B, Braga Neto MB, Bledsoe AC, Quinn KP, Heron V, Willrich MAV, Johnson A, Chedid VG, Coelho-Prabhu N, Kisiel JB, Papadakis KA, Pardi D, Kane S, Tremaine WJ, Raffals L, Bruining DH, Faubion WA, Harmsen WS, Loftus EV Jr. Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience. Crohns Colitis 360. 2021 Jul; 3 (3):otab019 Epub 2021 May 17
    View PubMed
38. Ebner DW, Eckmann JD, Burger KN, Mahoney DW, Bering J, Kahn A, Rodriguez EA, Prichard DO, Wallace MB, Kane SV, Finney Rutten LJ, Gurudu SR, Kisiel JB. Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA. Clin Transl Gastroenterol. 2021 Jun 18; 12 (6):e00375 Epub 2021 June 18
    View PubMed
39. Guerrero Vinsard D, Kane SV. Biologics and pregnancy: a clinician's guide to the management of IBD in pregnant women. Expert Rev Gastroenterol Hepatol. 2021 Jun; 15 (6):633-641 Epub 2021 Jan 25
    View PubMed
40. Piovezani Ramos G, Kane S. Alcohol Use in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2021 May; 17 (5):211-225
    View PubMed
41. Coelho-Prabhu N, Bruining DH, Faubion WA, Kane SV, Kisiel JB, Papadakis KA, Pardi DS, Raffals LE, Schroeder KW, Tremaine WJ, Fruth K, Harmsen WS, Loftus EV. A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy. Inflamm Bowel Dis. 2021 Apr 15; 27 (5):594-602
    View PubMed
42. Gaidos JKJ, Hass DJ, Kane SV. How to Strategically Build Your Network for Early Career Gastroenterologists. Gastroenterology. 2021 Apr; 160 (5):1461-1466 Epub 2021 Jan 15
    View PubMed
43. Kwapisz L, Raffals LE, Bruining DH, Pardi DS, Tremaine WJ, Kane SV, Papadakis KA, Coelho-Prabhu N, Kisiel JB, Heron V, Faubion WA, Loftus EV Jr. Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center. Clin Gastroenterol Hepatol. 2021 Mar; 19 (3):616-617 Epub 2020 Feb 14
    View PubMed
44. Narang K, Szymanski LM, Kane SV, Rose CH. Acute Pancreatitis in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2021 Mar 1; 137 (3):431-433
    View PubMed
45. Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, Cohen RD, Chambers CD, Sandborn WJ, Crohn's Colitis Foundation Clinical Research Alliance. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. Gastroenterology. 2021 Mar; 160 (4):1131-1139 Epub 2020 Nov 21
    View PubMed
46. Coelho-Prabhu N, Kane S. Does Size Really Matter? Am J Gastroenterol 2021 Jan 1; 116 (1):84-85
    View PubMed
47. Dulai PS, Singh S, Vande Casteele N, Meserve J, Winters A, Chablaney S, Aniwan S, Shashi P, Kochhar G, Weiss A, Koliani-Pace JL, Gao Y, Boland BS, Chang JT, Faleck D, Hirten R, Ungaro R, Lukin D, Sultan K, Hudesman D, Chang S, Bohm M, Varma S, Fischer M, Shmidt E, Swaminath A, Gupta N, Rosario M, Jairath V, Guizzetti L, Feagan BG, Siegel CA, Shen B, Kane S, Loftus EV Jr, Sandborn WJ, Sands BE, Colombel JF, Lasch K, Cao C. Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 Dec; 18 (13):2952-2961.e8 Epub 2020 Feb 13
    View PubMed
48. Lightner AL, Vogel JD, Carmichael JC, Keller DS, Shah SA, Mahadevan U, Kane SV, Paquette IM, Steele SR, Feingold DL. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's Disease. Dis Colon Rectum. 2020 Aug; 63 (8):1028-1052
    View PubMed
49. Bohm M, Xu R, Zhang Y, Varma S, Fischer M, Kochhar G, Boland B, Singh S, Hirten R, Ungaro R, Shmidt E, Lasch K, Jairaith V, Hudesman D, Chang S, Lukin D, Swaminath A, Sands BE, Colombel JF, Kane S, Loftus EV Jr, Shen B, Siegel CA, Sandborn WJ, Dulai PS, VICTORY Collaboration. Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease. Aliment Pharmacol Ther. 2020 Aug; 52 (4):669-681 Epub 2020 July 13
    View PubMed
50. Ji H, Chen ZE, Kane SV. Small Bowel Pseudomelanosis. Mayo Clin Proc. 2020 Jul; 95 (7):1430-1431
    View PubMed
51. Kane SV. Preventing Perianal Disease: We Can Do Better. JAMA Netw Open 2020 Jun 1; 3 (6):e208041 Epub 2020 June 01
    View PubMed
52. Chedid VG, Kane SV. Bone Health in Patients With Inflammatory Bowel Diseases. J Clin Densitom. 2020 Apr - Jun; 23 (2):182-189 Epub 2019 July 13
    View PubMed
53. Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario M, Feagan BG, Bojic D, Trang-Poisson C, Shen B, Altwegg R, Sands BE, Colombel JF, Carbonnel F, GETAID OBSERV-IBD, VICTORY Cohorts Collaboration*. A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease. Aliment Pharmacol Ther. 2020 Mar; 51 (5):553-564 Epub 2019 Dec 22
    View PubMed
54. Park SH, Al-Bawardy B, Aniwan S, Kane SV, Coelho-Prabhu N, Papadakis KA, Kisiel JB, Bruining DH, Faubion WA, Raffals LE, Pardi DS, Tremaine WJ, Stephens MC, Tung J, Khanna S, Willrich, Loftus EV. Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease. Crohn's & Colitis 360. 2019; 1(3):otz047.
    
55. Faleck DM, Winters A, Chablaney S, Shashi P, Meserve J, Weiss A, Aniwan S, Koliani-Pace JL, Kochhar G, Boland BS, Singh S, Hirten R, Shmidt E, Kesar V, Lasch K, Luo M, Bohm M, Varma S, Fischer M, Hudesman D, Chang S, Lukin D, Sultan K, Swaminath A, Gupta N, Siegel CA, Shen B, Sandborn WJ, Kane S, Loftus EV Jr, Sands BE, Colombel JF, Dulai PS, Ungaro R. Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019 Nov; 17 (12):2497-2505.e1 Epub 2019 Jan 06
    View PubMed
56. Koliani-Pace JL, Singh S, Luo M, Hirten R, Aniwan S, Kochhar G, Chang S, Lukin D, Gao Y, Bohm M, Swaminath A, Gupta N, Shmidt E, Meserve J, Winters A, Chablaney S, Faleck DM, Yang J, Huang Z, Boland BS, Shashi P, Weiss A, Hudesman D, Varma S, Fischer M, Sultan K, Shen B, Kane S, Loftus EV, Sands BE, Colombel JF, Sandborn WJ, Lasch K, Siegel CA, Dulai PS. Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes. Inflamm Bowel Dis. 2019 Oct 18; 25 (11):1854-1861
    View PubMed
57. Kane S. Contraception and Antibiotics. Inflamm Bowel Dis 2019 Oct 18; 25 (11):e148
    View PubMed
58. Moran K, Null K, Huang Z, Lissoos T, Kane S. Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases. Adv Ther. 2019 Sep; 36 (9):2260-2272 Epub 2019 Aug 05
    View PubMed
59. Aniwan S, Bruining DH, Park SH, Al-Bawardy B, Kane SV, Coelho Prabhu N, Kisiel JB, Raffals LE, Papadakis KA, Pardi DS, Tremaine WJ, Loftus EV Jr. The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis. J Clin Med. 2019 Aug 5; 8 (8) Epub 2019 Aug 05
    View PubMed
60. Meserve J, Aniwan S, Koliani-Pace JL, Shashi P, Weiss A, Faleck D, Winters A, Chablaney S, Kochhar G, Boland BS, Singh S, Hirten R, Shmidt E, Hartke JG, Chilukuri P, Bohm M, Sagi SV, Fischer M, Lukin D, Hudesman D, Chang S, Gao Y, Sultan K, Swaminath A, Gupta N, Kane S, Loftus EV Jr, Shen B, Sands BE, Colombel JF, Siegel CA, Sandborn WJ, Dulai PS. Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 Jul; 17 (8):1533-1540.e2 Epub 2018 Sept 27
    View PubMed
61. Kane S. Leter to the Editor. Inflamm Bowel Dis 2019 Apr 11; 25 (5):e52
    View PubMed
62. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology. 2019 Apr; 156 (5):1508-1524 Epub 2019 Jan 16
    View PubMed
63. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Am J Obstet Gynecol. 2019 Apr; 220 (4):308-323
    View PubMed
64. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Inflamm Bowel Dis. 2019 Mar 14; 25 (4):627-641
    View PubMed
65. Ananthakrishnan AN, Martin C, Kane S, Sandler RS, Long MD. Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 Jan; 17 (1):203-204 Epub 2018 Apr 11
    View PubMed
66. Chaudrey K, Shmidt E, Singh S, Kane S, Loftus EV, Sandborn WJ. Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium. Am J Gastroenterol. 2018 Dec; 113 (12):1912
    View PubMed
67. Elia J, Kane S. Adult Inflammatory Bowel Disease, Physical Rehabilitation, and Structured Exercise. Inflamm Bowel Dis. 2018 Nov 29; 24 (12):2543-2549
    View PubMed
68. Shmidt E, Kochhar G, Hartke J, Chilukuri P, Meserve J, Chaudrey K, Koliani-Pace JL, Hirten R, Faleck D, Barocas M, Luo M, Lasch K, Boland BS, Singh S, Vande Casteele N, Sagi SV, Fischer M, Chang S, Bohm M, Lukin D, Sultan K, Swaminath A, Hudesman D, Gupta N, Kane S, Loftus EV Jr, Sandborn WJ, Siegel CA, Sands BE, Colombel JF, Shen B, Dulai PS. Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 Oct 12; 24 (11):2461-2467
    View PubMed
69. Aniwan S, Harmsen WS, Tremaine WJ, Kane SV, Loftus EV. Overall and Cause-Specific Mortality of Inflammatory Bowel Disease in Olmsted County, Minnesota, From 1970 Through 2016. Mayo Clin Proc. 2018 Oct; 93 (10):1415-1422 Epub 2018 July 04
    View PubMed
70. Narula N, Peerani F, Meserve J, Kochhar G, Chaudrey K, Hartke J, Chilukuri P, Koliani-Pace J, Winters A, Katta L, Shmidt E, Hirten R, Faleck D, Parikh MP, Whitehead D, Boland BS, Singh S, Sagi SV, Fischer M, Chang S, Barocas M, Luo M, Lasch K, Bohm M, Lukin D, Sultan K, Swaminath A, Hudesman D, Gupta N, Shen B, Kane S, Loftus EV, Siegel CA, Sands BE, Colombel JF, Sandborn WJ, Dulai PS. Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium. Am J Gastroenterol. 2018 Sep; 113 (9):1345 Epub 2018 June 27
    View PubMed
71. Dulai PS, Boland BS, Singh S, Chaudrey K, Koliani-Pace JL, Kochhar G, Parikh MP, Shmidt E, Hartke J, Chilukuri P, Meserve J, Whitehead D, Hirten R, Winters AC, Katta LG, Peerani F, Narula N, Sultan K, Swaminath A, Bohm M, Lukin D, Hudesman D, Chang JT, Rivera-Nieves J, Jairath V, Zou GY, Feagan BG, Shen B, Siegel CA, Loftus EV Jr, Kane S, Sands BE, Colombel JF, Sandborn WJ, Lasch K, Cao C. Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease. Gastroenterology. 2018 Sep; 155 (3):687-695.e10 Epub 2018 May 30
    View PubMed
72. Kane SV, Chandrasekhara V, Sedlack RE, Buttar NS. Credentialing for Endoscopic Practice: The Mayo Clinic Model. Clin Gastroenterol Hepatol. 2018 Sep; 16 (9):1370-1373.e1 Epub 2018 June 18
    View PubMed
73. McConnell RA, Kane SV. The Potential and Pitfalls of Using the Electronic Health Record to Measure Quality. Am J Gastroenterol. 2018 Aug; 113 (8):1111-1113 Epub 2018 June 11
    View PubMed
74. Hansel SL, McCurdy JD, Barlow JM, Fidler J, Fletcher JG, Becker B, Prabhu NC, Faubion WA, Hanson KA, Kane SV, Kisiel JB, Loftus EV Jr, Papadakis KA, Pardi DS, Raffals LE, Schoenoff S, Tremaine WJ, Bruining DH. Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement. Inflamm Bowel Dis. 2018 Jun 8; 24 (7):1582-1588
    View PubMed
75. Mouchli MA, Singh S, Boardman L, Bruining DH, Lightner AL, Rosen CB, Heimbach JK, Hasan B, Poterucha JJ, Watt KD, Kane SV, Raffals LE, Loftus EV. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Inflamm Bowel Dis. 2018 Apr 23; 24 (5):1074-1081
    View PubMed
76. Mir FA, Kane SV. Health Maintenance in Inflammatory Bowel Disease. Curr Gastroenterol Rep. 2018 Apr 17; 20 (5):23
    View PubMed
77. Bonthala N, Kane S. Updates on Women's Health Issues in Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2018 Mar; 16 (1):86-100
    View PubMed
78. Kane S. Letter to the Editor: Missed Meals While Hospitalized for UC. Inflamm Bowel Dis 2018 Feb 15; 24 (3):660
    View PubMed
79. Aniwan S, Tremaine WJ, Raffals LE, Kane SV, Loftus EV Jr. Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study. J Crohns Colitis. 2018 Jan 24; 12 (2):137-144
    View PubMed
80. Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines. Clin Gastroenterol Hepatol. 2018 Jan; 16 (1):99-105 Epub 2017 Sept 01
    View PubMed
81. Hujoel IA, Rubio-Tapia A, Dao LN, Porrata LF, Kane SV. Epstein-Barr Virus-Positive Mucocutaneous Ulcer in an Immunosuppressed Patient. ACG Case Rep J. 2018; 5:e32 Epub 2018 Apr 25
    View PubMed
82. Afzali A, Ciorba MA, Schwartz DA, Sharaf M, Fourment C, Ritter T, Wolf DC, Shafran I, Randall CW, Kane SV. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Inflamm Bowel Dis. 2017 Dec 19; 24 (1):2-4
    View PubMed
83. Badshah MB, Walayat S, Ahmed U, Dhillon S, Yong S, Kane S, Thievanayagam S. Treatment of orofacial granulomatosis: a case report. J Med Case Rep. 2017 Oct 25; 11 (1):300
    View PubMed
84. Gaidos JKJ, Kane SV. Sexuality, Fertility, and Pregnancy in Crohn's Disease. Gastroenterol Clin North Am. 2017 Sep; 46 (3):531-546 Epub 2017 July 19
    View PubMed
85. Blevins CH, Kane SV. Importance of Considering the Financial Cost in Assessing Quality of Care. Inflamm Bowel Dis 2017 Sep; 23 (9):E47-E48
    View PubMed
86. Kane SV. Health Maintenance Assessment for Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017 Aug; 13 (8):500-503
    View PubMed
87. Martin T, Smukalla SM, Kane S, Hudesman DP, Greene R, Malter LB. Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease: A Clinical Review. Inflamm Bowel Dis. 2017 Aug; 23 (8):1285-1292
    View PubMed
88. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017 Jul; 112 (7):1208 Epub 2017 May 23
    View PubMed
89. Visrodia K, Abu Dayyeh B, Kane S. Crohn's and a Cough: Connecting the Dots. Gastroenterology. 2017 Jul; 153 (1):21-22 Epub 2017 June 01
    View PubMed
90. Kane S, Buttar N, Gleeson F, Larson M, Song LWK, Yates R. The Impact on Endoscopic Resource Utilization After A Targeted Intervention for Cost-Minimization of EGD and Colonoscopy. Am J Gastroenterol 2017 Jun; 112 (6):968
    View PubMed
91. Hilscher MB, Niesen CR, Tynsky DA, Kane SV. Pre-Procedural Patient Education Reduces Fall Risk in an Outpatient Endoscopy Suite. Gastroenterol Nurs. 2017 May/Jun; 40 (3):216-221
    View PubMed
92. Gaidos JK, Kane SV. Managing IBD Therapies in Pregnancy. Curr Treat Options Gastroenterol. 2017 Mar; 15 (1):71-83
    View PubMed
93. Keefer L, Kane SV. Considering the Bidirectional Pathways Between Depression and IBD: Recommendations for Comprehensive IBD Care. Gastroenterol Hepatol (N Y). 2017 Mar; 13 (3):164-169
    View PubMed
94. Jin JJ, Keith PJ, Cummins NW, Kane SV, Pritt BS, Sanchez JL. Lysinibacillus massiliensis Panniculitis Masquerading as Erythema Nodosum: A Case Report. Open Forum Infect Dis. 2017 Spring; 4 (2):ofx072 Epub 2017 Apr 06
    View PubMed
95. Cross RK, Kane S. Integration of Telemedicine Into Clinical Gastroenterology and Hepatology Practice. Clin Gastroenterol Hepatol. 2017 Feb; 15 (2):175-181 Epub 2016 Dec 16
    View PubMed
96. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017 Feb; 112 (2):241-258 Epub 2017 Jan 10
    View PubMed
97. Parekh NK, Shah S, McMaster K, Speziale A, Yun L, Nguyen DL, Melmed G, Kane S. Effects of caregiver burden on quality of life and coping strategies utilized by caregivers of adult patients with inflammatory bowel disease. Ann Gastroenterol. 2017; 30 (1):89-95 Epub 2016 Sept 06
    View PubMed
98. Patel B, Butterfield JH, Weiler CR, Kane SV. Tolerance and Efficacy with Simultaneous Use of Two Monoclonal Antibodies for a Patient with Hypereosinophilic Syndrome and Ulcerative Colitis. Monoclon Antib Immunodiagn Immunother. 2016 Dec; 35 (6):300-303 Epub 2016 Dec 02
    View PubMed
99. Marshall AL, Zhang X, Lewis B, Kane S, Go RS. Sex-Based Disparities in the Use and Results of Gastrointestinal Procedures for Workup of Anemia Journal of Women’s Health, Issues & Care.2016;
    
100. Kane SV. To the Editor. Inflamm Bowel Dis 2016 Nov; 22 (11):E42-E43
     View PubMed
101. Dulai PS, Singh S, Jiang X, Peerani F, Narula N, Chaudrey K, Whitehead D, Hudesman D, Lukin D, Swaminath A, Shmidt E, Wang S, Boland BS, Chang JT, Kane S, Siegel CA, Loftus EV, Sandborn WJ, Sands BE, Colombel JF. The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium. Am J Gastroenterol. 2016 Aug; 111 (8):1147-55 Epub 2016 June 14
     View PubMed
102. Gaidos JK, Kane SV. Overcoming challenges of treating inflammatory bowel disease in pregnancy. Expert Rev Clin Immunol. 2016 Aug; 12: (8)871-8.
     View PubMed
103. Kane S. IBD: Assisted reproductive technology less successful in ulcerative colitis. Nat Rev Gastroenterol Hepatol 2016 Jun; 13 (6):318-20 Epub 2016 May 05
     View PubMed
104. Feagins LA, Kane SV. Caring for Women with Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2016 Jun; 45: (2)303-15.
     View PubMed
105. Sheibani S, Cohen R, Kane S, Dubinsky M, Church JA, Mahadevan U. The Effect of Maternal Peripartum Anti-TNFalpha Use on Infant Immune Response. Dig Dis Sci. 2016 Jun; 61 (6):1622-7 Epub 2016 Jan 02
     View PubMed
106. Martin J, Kane SV, Feagins LA. Fertility and Contraception in Women With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016 Feb; 12 (2):101-9
     View PubMed
107. Fairchild EM, Lambert KL, Talley MI, Gleason A, Wengert H, Bohlen D, Elpert L, Bryant-Sendek D, Larson MV, Majka AJ, Kane SV. Cross-Site Scheduling of Endoscopic Procedures Improves Efficiency While Maintaining Patient Safety. J Healthc Qual. 2016 Jan-Feb; 38: (1)24-33.
     View PubMed
108. Tabibian JH, Yang JD, Baron TH, Kane SV, Enders FB, Gostout CJ. Weekend Admission for Acute Cholangitis Does Not Adversely Impact Clinical or Endoscopic Outcomes. Dig Dis Sci. 2016 Jan; 61 (1):53-61 Epub 2015 Sept 21
     View PubMed
109. Herman ML, Kane SV. Treatment Nonadherence in Inflammatory Bowel Disease: Identification, Scope, and Management Strategies. Inflamm Bowel Dis. 2015 Dec; 21 (12):2979-84
     View PubMed
110. Sifuentes H, Kane S. Monitoring for Extra-Intestinal Cancers in IBD. Curr Gastroenterol Rep. 2015 Nov; 17 (11):42
     View PubMed
111. Rosenblatt E, Kane S. Sex-Specific Issues in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2015 Sep; 11 (9):592-601
     View PubMed
112. Moon W, Pestana L, Becker B, Loftus EV Jr, Hanson KA, Bruining DH, Tremaine WJ, Kane SV. Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice. Aliment Pharmacol Ther. 2015 Aug; 42 (4):428-40 Epub 2015 June 17
     View PubMed
113. Beery RM, Kane SV. Management of Crohn's disease in pregnancy. Br J Hosp Med (Lond). 2015 Aug; 76: (8)455-63.
     View PubMed
114. Tabibian A, Tabibian JH, Beckman LJ, Raffals LL, Papadakis KA, Kane SV. Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management. Dig Dis Sci. 2015 May; 60 (5):1366-74 Epub 2015 Jan 06
     View PubMed
115. Chaudrey KH, Kane SV. Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy. Curr Treat Options Gastroenterol. 2015 Mar; 13: (1)77-89.
     View PubMed
116. Hashash JG, Kane S. Pregnancy and Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2015 Feb; 11 (2):96-102
     View PubMed
117. Francis DL, Kane SV, Prabhakar S, Petersen BT. Validation of a multidisciplinary infrastructure to capture adverse events in a high-volume endoscopy unit. Clin Gastroenterol Hepatol. 2015 Feb; 13 (2):221-227.e1 Epub 2014 Oct 02
     View PubMed
118. Vrabie R, Kane S. Noninvasive Markers of Disease Activity in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2014 Sep; 10 (9):576-84
     View PubMed
119. Kane SV, Jaganathan S, Bedenbaugh AV, Palmer L, Schwartz DA. Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease. Curr Med Res Opin. 2014 Sep; 30 (9):1821-6 Epub 2014 June 02
     View PubMed
120. Horst S, Kane S. The use of biologic agents in pregnancy and breastfeeding. Gastroenterol Clin North Am. 2014 Sep; 43 (3):495-508 Epub 2014 July 05
     View PubMed
121. De Felice KM, Kane SV. Inflammatory bowel disease in women of reproductive age. Expert Rev Gastroenterol Hepatol. 2014 May; 8(4):417-25. Epub 2014 Mar 03.
     View PubMed
122. Weber NK, Fidler JL, Keaveny TM, Clarke BL, Khosla S, Fletcher JG, Lee DC, Pardi DS, Loftus EV Jr, Kane SV, Barlow JM, Murthy NS, Becker BD, Bruining DH. Validation of a CT-derived method for osteoporosis screening in IBD patients undergoing contrast-enhanced CT enterography. Am J Gastroenterol. 2014 Mar; 109 (3):401-8 Epub 2014 Jan 21
     View PubMed
123. Singh S, Nagpal SJ, Murad MH, Yadav S, Kane SV, Pardi DS, Talwalkar JA, Loftus EV Jr. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014 Feb; 12 (2):210-8 Epub 2013 May 02
     View PubMed
124. Marchioni Beery R, Kane S. Current approaches to the management of new-onset ulcerative colitis. Clin Exp Gastroenterol. 2014; 7:111-32 Epub 2014 May 09
     View PubMed
125. Haq O, Ali T, Madhoun MF, Kane SV. Physician knowledge regarding concomitant antibiotic and oral contraceptive use in patients with IBD. Gastroenterol. Hepatol. 2014; 10(5):302-6.
     
126. Ludvigsson JF, Bergquist A, Ajne G, Kane S, Ekbom A, Stephansson O. A population-based cohort study of pregnancy outcomes among women with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2014 Jan; 12 (1):95-100.e1 Epub 2013 July 23
     View PubMed
127. Kane SV, Neis B, Becker BD, Bruining D, Faubion WA, Kisiel J, Loftus EV Jr, Pardi D, Raffals L, Schroeder K, Tremaine WJ. Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease. Aliment Pharmacol Ther 2013 Dec; 38 (11-12):1412
     View PubMed
128. Kane SV. Inflammatory bowel disease, women, and pregnancy. Gastroenterol Hepatol (N Y). 2013 Nov; 9 (11):741-3
     View PubMed
129. Yarur A, Kane SV. Update on pregnancy and breastfeeding in the era of biologics. Dig Liver Dis. 2013 Oct; 45(10):787-94. Epub 2013 Mar 06.
     View PubMed
130. McCurdy JD, Loftus EV Jr, Tremaine WJ, Smyrk TC, Bruining DH, Pardi DS, Raffals LE, Kisiel JB, Coelho-Prabhu N, Kane SV, Faubion WA, Papadakis KA. Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes. Inflamm Bowel Dis. 2013 Oct; 19 (11):2394-9
     View PubMed
131. Abraham NS, Richardson P, Castillo D, Kane SV. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Oct; 11(10):1281-7. Epub 2013 Jun 19.
     View PubMed
132. Abraham NS, Richardson P, Castillo D, Kane S. WITHDRAWN: Dual Therapy With Infliximab and Immunomodulator Reduces 1-Year Rates of Hospitalization and Surgery Among Veterans With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2013 Jul 23 Epub 2013 July 23
     View PubMed
133. Neis B, Hart P, Chandran V, Kane S. Mucosal schwann cell hamartoma of the colon in a patient with ulcerative colitis. Gastroenterol Hepatol (N Y). 2013 Mar; 9(3):183-5.
     View PubMed
134. Singh S, Kumar N, Loftus EV Jr, Kane SV. Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics. Inflamm Bowel Dis. 2013 Mar-Apr; 19 (4):864-72
     View PubMed
135. Hodgkins P, Yen L, Yarlas A, Karlstadt R, Solomon D, Kane S. Impact of MMX(R) mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis. Inflamm Bowel Dis. 2013 Feb; 19(2):386-96.
     View PubMed
136. Kane S, Leighton J, Kefalas C, Cohen L, Katz P, Rizk M, Pike I, Lashner B, Ho I, Pochapin M, Seabrook M, Greenwald D, Demarco D, Johnson D. Quality commitment: the newly established American College of Gastroenterology Quality Council to meet the needs of clinical gastroenterology. Am J Gastroenterol. 2013 Jan; 108(1):7-9.
     View PubMed
137. Samuel S, Bruining DH, Loftus EV Jr, Thia KT, Schroeder KW, Tremaine WJ, Faubion WA, Kane SV, Pardi DS, de Groen PC, Harmsen WS, Zinsmeister AR, Sandborn WJ. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol. 2013 Jan; 11 (1):49-54.e1 Epub 2012 Aug 16
     View PubMed
138. Kane S. Establishing an inflammatory bowel disease practice in an accountable world. Clin Gastroenterol Hepatol. 2012 Dec; 10(12):1301-4.
     View PubMed
139. Kane SV, Horst S, Sandborn WJ, Becker B, Neis B, Moscandrew M, Hanson KA, Tremaine WJ, Bruining DH, Faubion WA, Pardi DS, Harmsen WS, Zinsmeister AR, Loftus EV. Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experience. Inflamm Bowel Dis. 2012 Dec; 18 (12):2203-8 Epub 2012 Mar 14
     View PubMed
140. Horst SN, Kane S. Multi-Matrix System (MMX(R)) mesalamine for the treatment of mild-to-moderate ulcerative colitis. Expert Opin Pharmacother. 2012 Oct; 13(15):2225-32. Epub 2012 Sep 13.
     View PubMed
141. Kane S. What physicians don't know about patient dietary beliefs and behavior can make a difference. Expert Rev Gastroenterol Hepatol. 2012 Sep; 6(5):545-7.
     View PubMed
142. Bernick SJ, Kane S. Drug transfer to the fetus and to the breastfeeding infant: what do we know? Curr Drug Deliv. 2012 Jul; 9(4):350-5.
     View PubMed
143. Solomon D, Yarlas A, Hodgkins P, Karlstadt R, Yen L, Kane S. The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients. Aliment Pharmacol Ther. 2012 Jun; 35(12):1386-96. Epub 2012 Apr 27.
     View PubMed
144. Abraham BP, Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am. 2012 Jun; 41(2):483-95. Epub 2012 Feb 16.
     View PubMed
145. Kane S, Katz S, Jamal MM, Safdi M, Dolin B, Solomon D, Palmen M, Barrett K. Strategies in maintenance for patients receiving long-term therapy (SIMPLE): a study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis. Inflamm Bowel Dis. 2012 Jun; 18 (6):1026-33 Epub 2011 Aug 11
     View PubMed
146. Grigg EL, Kane S, Katz S. Mimicry and deception in inflammatory bowel disease and intestinal behcet disease. Gastroenterol Hepatol (N Y). 2012 Feb; 8 (2):103-12
     View PubMed
147. Kane S, Becker B, Harmsen WS, Kurian A, Morisky DE, Zinsmeister AR. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease. Am J Gastroenterol. 2012 Feb; 107(2):154-60.
     View PubMed
148. Wasan SK, Kane SV. Adalimumab for the treatment of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2011 Dec; 5(6):679-84.
     View PubMed
149. Lahiff C, Kane S, Moss AC. Drug development in inflammatory bowel disease: the role of the FDA. Inflamm Bowel Dis. 2011 Dec; 17(12):2585-93. Epub 2011 Apr 11.
     View PubMed
150. Kane SV, Sumner M, Solomon D, Jenkins M. Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database. Dig Dis Sci. 2011 Dec; 56 (12):3463-70 Epub 2011 Aug 31
     View PubMed
151. Ford AC, Khan KJ, Sandborn WJ, Kane SV, Moayyedi P. Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011 Dec; 106(12):2070-7; quiz 2078. Epub 2011 Sep 06.
     View PubMed
152. Kowalczyk R, Kane S. Inflammatory Bowel Disease: A Primary Care Primer. Consultant. 2011 Oct; 51(10):713-8.
     
153. Feagins LA, Holubar SD, Kane SV, Spechler SJ. Current strategies in the management of intra-abdominal abscesses in Crohn's disease. Clin Gastroenterol Hepatol. 2011 Oct; 9(10):842-50. Epub 2011 May 05.
     View PubMed
154. Kane SV. Preparing for biologic or immunosuppressant therapy. Gastroenterol Hepatol (N Y). 2011 Aug; 7 (8):544-6
     View PubMed
155. Flynn A, Kane S. Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us? Curr Opin Gastroenterol. 2011 Jul; 27(4):342-5.
     View PubMed
156. Beaulieu DB, Kane S. Inflammatory bowel disease in pregnancy. World J Gastroenterol. 2011 Jun 14; 17(22):2696-701.
     View PubMed
157. Thia KT, Loftus EV Jr, Pardi DS, Kane SV, Faubion WA, Tremaine WJ, Schroeder KW, Harmsen SW, Zinsmeister AR, Sandborn WJ. Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity. Inflamm Bowel Dis. 2011 Jun; 17 (6):1257-64 Epub 2010 Sept 27
     View PubMed
158. Beaulieu DB, Kane S. Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am. 2011 Jun; 40(2):399-413, ix. Epub 2011 Apr 06.
     View PubMed
159. Levesque BG, Kane SV. Searching for the delta: 5-aminosalicylic Acid therapy for Crohn's disease. Gastroenterol Hepatol (N Y). 2011 May; 7(5):295-301.
     View PubMed
160. Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P, American College of Gastroenterology IBD Task Force. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011 Apr; 106 Suppl 1:S2-25; quiz S26.
     View PubMed
161. Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):601-16. Epub 2011 Mar 15.
     View PubMed
162. Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):617-29. Epub 2011 Mar 15.
     View PubMed
163. Levesque BG, Kane SV. IBD: measuring what counts-safety of IBD medications in pregnancy. Nat Rev Gastroenterol Hepatol. 2011 Mar; 8 (3):126-8 Epub 2011 Feb 08
     View PubMed
164. Holubar SD, Kane S. Prevention and treatment of postproctectomy infertility. Semin. Colon Rectal Surg. 2011; 22(4):249-54.
     
165. Kane S. Preparing the patient for immunosuppressive therapy. Curr Gastroenterol Rep. 2010 Dec; 12 (6):502-6
     View PubMed
166. Kane SV, Robinson A. Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts. Aliment Pharmacol Ther. 2010 Nov; 32 (9):1051-8 Epub 2010 Sept 03
     View PubMed
167. Swoger JM, Loftus EV Jr, Tremaine WJ, Faubion WA, Pardi DS, Kane SV, Hanson KA, Harmsen WS, Zinsmeister AR, Sandborn WJ. Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patients. Inflamm Bowel Dis. 2010 Nov; 16 (11):1912-21
     View PubMed
168. Bernick SJ, Kane S. Insight into the widespread problem of nonadherence to therapy in ulcerative colitis patients. Expert Rev Clin Immunol. 2010 Jul; 6(4):677-82.
     View PubMed
169. Chang JY, Marks RS, Nagorney DM, Sanderson SO, Kane S. Ulcerative colitis, infliximab, and hepatic epithelioid hemangioendothelioma: who is to blame? Case Report. Therap Adv Gastroenterol. 2010 May; 3 (3):203-6
     View PubMed
170. Afif W, Loftus EV Jr, Faubion WA, Kane SV, Bruining DH, Hanson KA, Sandborn WJ. Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease. Am J Gastroenterol. 2010 May; 105 (5):1133-9 Epub 2010 Feb 09
     View PubMed
171. Travis AC, Katz PO, Kane SV. Mentoring in gastroenterology. Am J Gastroenterol. 2010 May; 105(5):970-2.
     View PubMed
172. Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis. Gastroenterology. 2010 Apr; 138(4):1286-96, 1296.e1-3. Epub 2010 Jan 11.
     View PubMed
173. Rubin DT, Dubinsky MC, Panaccione R, Siegel CA, Binion DG, Kane SV, Hopper J. The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci. 2010 Apr; 55(4):1044-52. Epub 2009 Sep 04.
     View PubMed
174. Kane S. Does treatment schedule matter? Once daily versus divided doses of 5-ASAs. Dig Dis. 2010; 28(3):478-82. Epub 2010 Sep 30.
     View PubMed
175. Bernick SJ, Kane S. Improving adherence in inflammatory bowel disease. Pract Gastroenterol. 2010; 34(2):17-22.
     
176. Kane S. A 38-year-old with recurrent colitis. Is it noncompliance? Clin Gastroenterol Hepatol. 2009 Nov; 7(11):1164-7. Epub 2009 Jul 01.
     View PubMed
177. Moscandrew M, Kane S. Inflammatory bowel diseases and management considerations: fertility and pregnancy. Curr Gastroenterol Rep. 2009 Oct; 11 (5):395-9
     View PubMed
178. Kane SV, Chao J, Mulani PM. Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients. Adv Ther. 2009 Oct; 26 (10):936-46 Epub 2009 Oct 16
     View PubMed
179. Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflamm Bowel Dis. 2009 Sep; 15 (9):1399-409
     View PubMed
180. Afif W, Leighton JA, Hanauer SB, Loftus EV Jr, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ. Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflamm Bowel Dis. 2009 Sep; 15 (9):1302-7
     View PubMed
181. Kane S, Ford J, Cohen R, Wagner C. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol. 2009 Aug; 43(7):613-6.
     View PubMed
182. Kane S, Lu F, Kornbluth A, Awais D, Higgins PD. Controversies in mucosal healing in ulcerative colitis. Inflamm Bowel Dis. 2009 May; 15 (5):796-800
     View PubMed
183. Kane SV, Accortt NA, Magowan S, Brixner D. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis. Aliment Pharmacol Ther. 2009 Apr 15; 29 (8):855-62 Epub 2009 Jan 17
     View PubMed
184. Okoro NI, Kane SV. Gender-related issues in the female inflammatory bowel disease patient. Expert Rev Gastroenterol Hepatol. 2009 Apr; 3(2):145-54.
     View PubMed
185. Kane SV, Acquah LA. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol. 2009 Jan; 104 (1):228-33
     View PubMed
186. Kane S. Endoscopic healing should be a goal for everyone with ulcerative colitis. Inflamm Bowel Dis. 2008 Nov 4 Epub 2008 Nov 04
     View PubMed
187. Kane S. What are the minimal requirements for a diagnosis of inflammatory bowel disease? Inflamm Bowel Dis. 2008 Oct; 14 Suppl 2:S148-9
     View PubMed
188. Hutfless S, Fireman B, Kane S, Herrinton LJ. Screening differences and risk of cervical cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2008 Sep 1; 28(5):598-605. Epub 2008 Jun 28.
     View PubMed
189. Kane SV, Loftus EV Jr, Dubinsky MC, Sederman R. Disease perceptions among people with Crohn's disease. Inflamm Bowel Dis. 2008 Aug; 14 (8):1097-101
     View PubMed
190. Kane S. Abnormal Pap smears in inflammatory bowel disease. Inflamm Bowel Dis. 2008 Aug; 14 (8):1158-60
     View PubMed
191. Kane SV, Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2008 May; 103(5):1193-6. Epub 2008 Jan 02.
     View PubMed
192. Quin A, Kane S, Ulitsky O. A case of fistulizing Crohn's disease and erythema nodosum managed with adalimumab. Nat Clin Pract Gastroenterol Hepatol. 2008 May; 5(5):278-81. Epub 2008 Mar 25.
     View PubMed
193. Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008 Apr; 53 (4):1020-4 Epub 2007 Oct 13
     View PubMed
194. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008 Mar; 103 (3):631-6 Epub 2007 Oct 17
     View PubMed
195. Shugart YY, Silverberg MS, Duerr RH, Taylor KD, Wang MH, Zarfas K, Schumm LP, Bromfield G, Steinhart AH, Griffiths AM, Kane SV, Barmada MM, Rotter JI, Mei L, Bernstein CN, Bayless TM, Langelier D, Cohen A, Bitton A, Rioux JD, Cho JH, Brant SR. An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29. Genes Immun. 2008 Mar; 9(2):161-7. Epub 2008 Jan 31.
     View PubMed
196. Kane S, Holderman W, Jacques P, Miodek T. Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial. Patient Prefer Adherence. 2008 Feb 2; 2:253-8 Epub 2008 Feb 02
     View PubMed
197. Selby L, Kane S, Wilson J, Balla P, Riff B, Bingcang C, Hoellein A, Pande S, de Villiers WJ. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008 Feb; 14(2):253-8.
     View PubMed
198. Okoro N, Kane S. Abnormal cervical cytology and inflammatory bowel disease: Impact of immunosuppression. Pract Gastroenterol. 2008; 32(11):33-4, 36.
     
199. Kane SV. Patient Adherence in IBD. Primary Care Quartlerly. 2008; 12(1):39-44.
     
200. Kane SV, Brixner D, Rubin DT, Sewitch MJ. The challenge of compliance and persistence: focus on ulcerative colitis. J Manag Care Pharm. 2008 Jan; 14 (1 Suppl A):s2-12; quiz s13-5
     View PubMed
201. Kane SV. Strategies to improve adherence and outcomes in patients with ulcerative colitis. Drugs. 2008; 68 (18):2601-9
     View PubMed
202. Kane SV. Overcoming adherence issues in ulcerative colitis. Gastroenterol Hepatol (N Y). 2007 Oct; 3 (10):795-9
     View PubMed
203. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007 Oct; 133(4):1106-12. Epub 2007 Jul 25.
     View PubMed
204. Dassopoulos T, Nguyen GC, Bitton A, Bromfield GP, Schumm LP, Wu Y, Elkadri A, Regueiro M, Siemanowski B, Torres EA, Gregory FJ, Kane SV, Harrell LE, Franchimont D, Achkar JP, Griffiths A, Brant SR, Rioux JD, Taylor KD, Duerr RH, Silverberg MS, Cho JH, Steinhart AH. Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). Inflamm Bowel Dis. 2007 Aug; 13(8):975-83.
     View PubMed
205. Silverberg MS, Duerr RH, Brant SR, Bromfield G, Datta LW, Jani N, Kane SV, Rotter JI, Philip Schumm L, Hillary Steinhart A, Taylor KD, Yang H, Cho JH, Rioux JD, Daly MJ, NIDDK IBD Genetics Consortium. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet. 2007 Mar; 15(3):328-35. Epub 2007 Jan 10.
     View PubMed
206. Kane SV. The complexity of compliance and persistence in ulcerative colitis. Gastroenterol. Hepatol. 2007; 3(9 Suppl 28):3-10.
     
207. Parekh N, Kane S. The pregnant IBD patient: what every gastroenterologist should consider. Pract Gastroenterol. 2007; 31(2):17-28.
     
208. Zisman TL, Kane SV. Current and future therapies for inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2007; 1(1):89-100.
     
209. Kane S. Urogenital complications of Crohn's disease. Am J Gastroenterol. 2006 Dec; 101(12 Suppl):S640-3.
     View PubMed
210. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. 2006 Oct 17; 145(8):557-63.
     View PubMed
211. Kane S, Dixon L. Adherence rates with infliximab therapy in Crohn's disease. Aliment Pharmacol Ther. 2006 Oct 1; 24(7):1099-103.
     View PubMed
212. Kane S, Reddy D. Guidelines do help change behavior in the management of osteoporosis by gastroenterologists. Am J Gastroenterol. 2006 Aug; 101(8):1841-4. Epub 2006 Jun 30.
     View PubMed
213. Reddy D, Siegel CA, Sands BE, Kane S. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol. 2006 Jul; 101(7):1569-73.
     View PubMed
214. Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006 Jul; 131(1):283-311.
     View PubMed
215. Mahadevan U, Kane S. American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006 Jul; 131(1):278-82.
     View PubMed
216. Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, Dassopoulos T, Schumm P, Gregory FJ, Griffiths AM, Hanauer SB, Hanson J, Harris ML, Kane SV, Orkwis HK, Lahaie R, Oliva-Hemker M, Pare P, Wild GE, Rioux JD, Yang H, Duerr RH, Cho JH, Steinhart AH, Brant SR, Silverberg MS. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006 May; 101(5):1012-23.
     View PubMed
217. Kane SV. Asacol -- a review focusing on ulcerative colitis. US Gastroenterology Review. 2006 Mar:22-5.
     
218. Keswani RN, Sauk J, Kane SV. Factitious diarrhea masquerading as refractory celiac disease. South Med J. 2006 Mar; 99(3):293-5.
     View PubMed
219. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2006 Mar 1; 23(5):577-85.
     View PubMed
220. Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest. 2006 Feb; 86(2):191-201.
     View PubMed
221. Kane S. Colon lesions: pathology specific to women. Gastrointest Endosc Clin N Am. 2006 Jan; 16(1):165-73.
     View PubMed
222. Lichtenstein GR, Kane SV, Velayos FS. Short and long term benefits of successful mucosal healing and patient compliance in ulcerative colitis. Gastroenterology & Hepatology. 2006; 2(12):S1-10.
     
223. Kane SV. Another biologic for Crohn's disease: not so fast. Evid Based Gastroenterol. 2006; 7(2):5-6.
     
224. Kane SV. Best of DDW 2006. Gastroenterology & Hepatology. 2006; 2(7):521-4.
     
225. Loftus EV, Kane SV, Lichtensetein GR, Sandborn WJ. Contemporary management of ulcerative colitis: the patient's perspective. Gastroenterology & Hepatology. 2006; 2(9):4-15.
     
226. Giannini EG, Kane SV, Testa R, Savarino V. 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'? Dig Liver Dis. 2005 Oct; 37(10):723-31.
     View PubMed
227. Sauk J, Kane S. The use of medications for inflammatory bowel disease during pregnancy and nursing. Expert Opin Pharmacother. 2005 Sep; 6(11):1833-9.
     View PubMed
228. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther. 2005 Mar 15; 21(6):733-8.
     View PubMed
229. Kane S. Gender issues in the management of irritable bowel syndrome. Int J Fertil Womens Med. 2005 Mar-Apr; 50(2):79-82.
     View PubMed
230. Kane SV. Gender issues in inflammatory bowel diseases. Women's Health. 2005; 1(3):401-8.
     
231. Kane SV, DeVos M, Riley S, Frieri G, Mittman U. Compliance with IBD therapy: facts, concerns and ways forward. Rev Gastroenterol Disord. 2005; 5(2):101-5.
     
232. Kane SV. Controversies in IBD case management. Clinician. 2005; 23(1).
     
233. Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2005 Jan; 100(1):102-5.
     View PubMed
234. Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission. J Clin Gastroenterol. 2005 Jan; 39(1):32-5.
     View PubMed
235. Sandborn WJ, Hanauer S, Loftus EV Jr, Tremaine WJ, Kane S, Cohen R, Hanson K, Johnson T, Schmitt D, Jeche R. An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease. Am J Gastroenterol. 2004 Oct; 99 (10):1984-9
     View PubMed
236. Kane S, Cohen SM, Hart J. Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease. Inflamm Bowel Dis. 2004 Sep; 10(5):652-4.
     View PubMed
237. Kane S, Kisiel J, Shih L, Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am J Gastroenterol. 2004 Aug; 99(8):1523-6.
     View PubMed
238. Lichtenstein GR, Cuffari C, Kane SV, Hanauer S, Present DH. Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts. Inflamm Bowel Dis. 2004 Jul; 10 Suppl 2:S11-21.
     View PubMed
239. Lichtenstein GR, Hanauer SB, Kane SV, Present DH. Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease. Inflamm Bowel Dis. 2004 Jul; 10 Suppl 2:S2-10.
     View PubMed
240. Baker DE, Kane S. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Rev Gastroenterol Disord. 2004 Spring; 4(2):86-91.
     View PubMed
241. Loftus EV Jr, Kane SV, Bjorkman D. Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2004 Jan 15; 19 (2):179-89
     View PubMed
242. Kane SV. Adherence issues in the patient with inflammatory bowel disease. Pract Gastroenterol. 2004; 28(9):16-22.
     
243. Kane SV. Managing the pregnant patient with inflammatory bowel disease. Pract Gastroenterol. 2004; 28(10):16-26.
     
244. Kane SV. Breastfeeding and IBD: safety and management issues. Inflammatory Bowel Disease Monitor. 2004; 6(2):50-2.
     
245. Kane SV, Borisov NN, Brixner D. Pharmacoeconomic evaluation of gastrointestinal tract events during treatment with risedronate or alendronate: a retrospective cohort study. Am J Manag Care. 2004; 10:S216-26.
     
246. Kane SV. Another reason why immunomodulators are better than steroids: lack of asosciation with postoperative infections. Evid Based Gastroenterol. 2004; 5(1):26-7.
     
247. Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis. 2003 Sep; 9(5):281-9.
     View PubMed
248. Kane SV, Bjorkman DJ. The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review. Rev Gastroenterol Disord. 2003 Fall; 3(4):210-8.
     View PubMed
249. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003 Jun; 98(6):1309-14.
     View PubMed
250. Kane S, Huo D, Magnanti K. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin Gastroenterol Hepatol. 2003 May; 1(3):170-3.
     View PubMed
251. Tuvlin JA, Kane SV. Novel therapies in the treatment of ulcerative colitis. Expert Opin Investig Drugs. 2003 Mar; 12(3):483-90.
     View PubMed
252. Kane S. Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am. 2003 Mar; 32(1):323-40.
     View PubMed
253. Kane SV. Some reassuring news for 6-MP users. Evid Based Gastroenterol. 2003; 4(3):100-1.
     
254. Kane SV. Bugs as drugs: ready for the "mainstream"? Evid Based Gastroenterol. 2003; 4(4):135-6.
     
255. Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003 Jan; 114(1):39-43.
     View PubMed
256. Kane SV, Schoenfeld P, Sandborn WJ, Tremaine W, Hofer T, Feagan BG. The effectiveness of budesonide therapy for Crohn's disease. Aliment Pharmacol Ther. 2002 Aug; 16(8):1509-17.
     View PubMed
257. Kane S, Stone LJ, Ehrenpreis E. Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab: a case series. J Clin Gastroenterol. 2002 Aug; 35(2):149-50.
     View PubMed
258. Kane S. Gender issues in the management of inflammatory bowel disease and irritable bowel syndrome. Int J Fertil Womens Med. 2002 May-Jun; 47(3):136-42.
     View PubMed
259. Kane SV. Managing pregnancy in IBD. Inflammatory Bowel Disease Monitor. 2002; 4(1):1-12.
     
260. Kane SV. Yet another steroid that we will learn to avoid: beclometasone dipropionate for ulcerative colitis. Evid Based Gastroenterol. 2002; 3(1):92-4.
     
261. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001 Oct; 96(10):2929-33.
     View PubMed
262. Kane SV. Novel therapies in the treatment of ulcerative colitis. Expert Opin Investig Drugs. 2001 Jul; 10(7):1223-9.
     View PubMed
263. Kane SV. Non-steroidal anti-inflammatory drugs are associated with an increased risk of disease activity in inflammatory bowel disease. Evid Based Gastroenterol. 2001; 2(1):20-1.
     
264. Kane SV. Growth hormone for Crohn's disease: not the new wonder drug. Evid Based Gastroenterol. 2001; 2(1):28-9.
     
265. Kane SV. Is ursodiol protective against colorectal cancer in patients with ulcerative colitis and primary sclerosing cholangitis? Evid Based Gastroenterol. 2001; 2(2):70-1.
     
266. Kane SV. A decreased murine content does not necessarily equate to improved efficacy in targeted biologics. Evid Based Gastroenterol. 2001; 2(3):115.
     
267. Kane S. Caring for women with inflammatory bowel disease. J Gend Specif Med. 2001; 4(1):54-9.
     View PubMed
268. Kane S, Brasitus T. Histoplasmosis capsulatum as a cause of lower gastrointestinal bleeding in common variable immunodeficiency. Dig Dis Sci. 2000 Nov; 45(11):2133-5.
     View PubMed
269. Kane SV. Colorectal cancer surveillance of patients with ulcerative colitis is disorganized and inconsistent. Evid Based Gastroenterol. 2000; 1(1):20-1.
     
270. Kane SV. Methotrexate appear efficacious and safe for maintenance in Crohn's disease. Evid Based Gastroenterol. 2000; 1(2):70-1.
     
271. Ehrenpreis ED, Kane SV, Cohen LB, Cohen RD, Hanauer SB. Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. Gastroenterology. 1999 Dec; 117(6):1271-7.
     View PubMed
272. Kane S. Patient compliance and outcomes. Inflamm Bowel Dis. 1999 May; 5(2):134-7.
     View PubMed
273. Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol. 1998 Oct; 93(10):1867-72.
     View PubMed
274. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and ulcerative colitis. Gastroenterology. 1990 Oct; 99(4):1032-6.
     View PubMed
275. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol. 1990 Sep; 85(9):1083-7.
     View PubMed
276. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study. Gastroenterology. 1989 Dec; 97(6):1442-7.
     View PubMed
277. Lashner BA, Heidenreich PA, Su GL, Kane SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology. 1989 Aug; 97(2):255-9.
     View PubMed